Related Experiment Video
Updated: Feb 7, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Nogo-A inhibits vascular regeneration in ischemic retinopathy
Sandrine Joly1, Agnieszka Dejda2, Léa Rodriguez1
1CUO-Recherche, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, Université Laval, Quebec, Quebec, Canada.
Abstract:
Nogo-A is a potent glial-derived inhibitor of axon growth in the injured CNS and acts as a negative regulator of developmental angiogenesis by inhibiting vascular endothelial cell migration. However, its function in pathological angiogenesis has never been studied after ischemic injury in the CNS. Using the mouse model of oxygen-induced retinopathy (OIR) which yields defined zones of retinal ischemia, our goal was to investigate the role of Nogo-A in vascular regeneration. We demonstrate a marked upregulation of the Nogo-A receptor sphingosine 1-phosphate receptor 2 in blood vessels following OIR, while Nogo-A is abundantly expressed in surrounding glial cells. Acute inhibition of Nogo-A with function-blocking antibody 11C7 significantly improved vascular regeneration and consequently prevented pathological pre-retinal angiogenesis. Ultimately, inhibition of Nogo-A led to restoration of retinal function as determined by electrophysiological response of retinal cells to light stimulation. Our data suggest that anti-Nogo-A antibody may protect neuronal cells from ischemic damage by accelerating blood vessel repair in the CNS. Targeting Nogo-A by immunotherapy may improve CNS perfusion after vascular injuries.
Insights
Inhibition of Nogo-A, a glial-derived inhibitor, improved vascular regeneration and prevented pathological angiogenesis in the central nervous system (CNS). This therapeutic approach restored retinal function after ischemic injury.
Area of Science:
- Neuroscience
- Vascular Biology
- Ophthalmology
Background:
- Nogo-A inhibits axon growth and developmental angiogenesis.
- Its role in pathological angiogenesis post-CNS ischemic injury is unknown.
Purpose of the Study:
- Investigate Nogo-A's role in vascular regeneration after CNS ischemic injury.
- Assess the therapeutic potential of Nogo-A inhibition.
Main Methods:
- Utilized a mouse model of oxygen-induced retinopathy (OIR).
- Administered a function-blocking antibody (11C7) against Nogo-A.
- Evaluated vascular regeneration, angiogenesis, and retinal function.
Main Results:
- Nogo-A receptor (sphingosine 1-phosphate receptor 2) upregulated in OIR blood vessels.
- Nogo-A expressed by glial cells surrounding ischemic areas.
- Antibody treatment significantly improved vascular regeneration and prevented pathological angiogenesis.
- Restored retinal function, evidenced by electrophysiological responses.
Conclusions:
- Nogo-A inhibition promotes vascular repair in the CNS.
- Anti-Nogo-A therapy may protect neurons from ischemic damage by enhancing blood vessel repair.
- Targeting Nogo-A via immunotherapy could improve CNS perfusion after vascular injuries.
Related Concept Videos
Feedback Inhibition
Seedless Vascular Plants
Enzyme Inhibition
Inhibition of Cdk Activity
Whole Body Regeneration
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

